About the Tow Center for Developmental Oncology
The Tow Center for Developmental Oncology unites scientists across MSK to develop fundamental insights into the molecular mechanisms of cancers in children and young adults, and to devise new approaches for definitive therapy and control.
Learn more

Research of the Tow Center for Developmental Oncology

The Tow Center for Developmental Oncology has several ongoing research collaborations within and outside of MSKCC.

Learn more about our research

Andrew Kung, Chair, Department of Pediatrics

The Tow Center for Developmental Oncology brings together investigators from across all of MSK. This includes basic scientists from the Sloan Kettering Institute, experts from MSK Kids (MSK’s pediatric program), and physician-scientists from Memorial Hospital and the Human Oncology & Pathogenesis Program.

Meet our faculty

See publications and recent research from TCDO members here.

Our Awards

The Tow Center for Developmental Oncology funds internal investigators looking into the mechanisms of pediatric and young adult cancers.

Learn more about our awardees

Faculty Recruitment for the Tow Center for Developmental Oncology
The Tow Center for Developmental Oncology is recruiting scientists to join our world-renowned faculty conducting research focused on the biology, physiology, and molecular mechanisms of cancers in children and young adults. MSK’s ultimate goal is to make fundamental discoveries to develop definitive treatments for patients.
Apply to join our team MSK faculty: Learn how you can participate

Innovative Discoveries

Learn about our ongoing research.

MSK scientists Andrew Kung and Elli Papaemmanouil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Study Demonstrates the Reasons to Screen Children with Cancer for Inherited Cancer Genes
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
Pediatric oncologist Nai-Kong Cheung
Novel Treatment Pioneered by MSK Kids Researchers Receives FDA Approval for Patients with High-Risk Neuroblastoma
The US Food and Drug Administration (FDA) has approved the drug naxitamab (Danyelza) for the treatment of patients with high-risk neuroblastoma. The drug, also known as humanized 3F8, was developed by researchers at MSK Kids, the pediatric cancer program at Memorial Sloan Kettering.
Researchers Ahmet Zehir and Elli Papaemmanouil talk while looking at a computer.
Why Do Certain Chemotherapies Increase the Likelihood of Blood Cancer?
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.
In the Lab
Cancer biologist and pediatric oncologist Alex Kentsis
Analyzing Urine Can Guide the Treatment of Childhood Kidney Tumors
A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.
In the Lab
Mutlinucleated muscle cells from flies
Scientists Home In On “Equation” for Muscle Cell Size
A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.


View all news


Ping Chi
Our Donor Community Drives Progress

Essential philanthropic support from The Tow Foundation and other generous donors allows the Tow Center for Developmental Oncology to advance research and care for kids with cancer worldwide.

Learn how our community makes an impact


Our Staff

Gabriella Casalena
Gabriella Casalena

Scientific Research Manager

Katarzyna Kulej

Scientific Research Lead

Asher Preska Steinberg, PhD
Asher Preska Steinberg

Computational Biologist

Stephanie Tingue
Stephanie Tingue

Administrative Assistant

For any questions about TCDO or its activities, please reach out to [email protected].